FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> pandemic flu | WHO | swine flu | H1N1

WHO says H1N1 pandemic has run its course

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

The swine flu virus will be with us indefinitely, but the World Health Organization says that the H1N1 pandemic it triggered is over. For the vaccine industry, the pandemic presented an opportunity to do its best research work, turning out a new vaccine in record time, while highlighting how the world's manufacturing system still relies on old technology that is far too slow to guard against a wildfire breakout. Fortunately, the swine flu turned into a dry run of sorts. Far more mild than originally feared, it caused relatively few deaths. The next time around the virus may not be so unthreatening. In the meantime, a lineup of biotech companies has been working feverishly to develop new vaccines that can be made much faster. Story

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about pandemic flu   WHO   swine flu   H1N1